drugset / Trial / NCT01223079

Use of r-hLH (Luveris) in Donors Previously Treated With r-hFSH (Gonal F)

NCT01223079

Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of the study is to compare the safety and efficacy of r-hLH to r-hFSH in the late follicular phase of young women undergoing controlled ovarian stimulation for oocyte donation.

Timeline

Start
2005-12
Primary completion
2007-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonal-f Protein / enzyme biologic
Subject Luveris Protein / enzyme biologic 300 iu

Indications

No indication recorded.